Overview of the current role of stereotactic body radiotherapy in the treatment of unfavorable intermediate- and high-risk prostate cancer

Maris Mezeckis, Vesprini Danny, Buryk Vladyslav, Miszczyk Leszek, Vjaters Egils

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Overview of the current role of stereotactic body radiotherapy in the treatment of unfavorable intermediate- and high-risk prostate cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science